Skip to content

Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness

Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04769349
Enrollment
563
Registered
2021-02-24
Start date
2021-01-29
Completion date
2023-08-30
Last updated
2023-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Healthcare, Housing, Mental Health, Physical Health, Social Interaction

Brief summary

This study aims to understand the comparative effectiveness of two PSH models (PB-PSH and SS-PSH) on quality of life and COVID-19 related health behaviors by following for 6 months a cohort of 800 PEH who have been placed in either PB (n=400) or SS (n=400). In a natural observational experiment, participants will complete 6 monthly mobile-based questionnaires exploring quality of life including physical, mental, social, and housing/environmental health, COVID-19 prevention practices (i.e., handwashing, social distancing, face covering), and past-30-day healthcare utilization. A sub-sample of 40 participants living in both PB-PSH and SS-PSH will be qualitatively interviewed longitudinally to help contextualize quantitative findings. Focus groups will also be conducted with providers of PSH and qualitative interviews will be conducted with other key stakeholders to understand perspectives on the challenges of implementing and sustaining COVID-19 related prevention practices while maintaining a continuity of care.

Detailed description

This study will aim to understand the comparative effectiveness of PB-PSH and SS-PSH on patient-centered quality of life, health care utilization, and health behaviors that will reduce COVID-19 risk by following a diverse sample of 800 PEH who are placed in PB-PSH (n = 400) or SS-PSH (n = 400) for 6 months. Barriers and facilitators will also be identified that may affect PSH implementation during the pandemic and its aftermath. The specific aims are: Aim 1: To test the comparative effectiveness of PB-PSH and SS-PSH on COVID-19-related health behaviors (COVID-19-related personal health practices including social distancing) for PEH over time. Aim 2: To test the comparative effectiveness of PB-PSH and SS-PSH on patient-centered quality of life (i.e., general life satisfaction; physical, mental, social, and environmental health) for PEH over time. Aim 3: To test the comparative effectiveness of PB-PSH and SS-PSH on health care utilization health behaviors and unmet need for care for physical health, mental health, substance use disorders, for PEH over time. Aim 4: To contextualize quantitative findings through longitudinal qualitative inquiry with 40 participants, purposively sampled from PB-PSH and SS-PSH, based on whether they are following social distancing guidelines. Aim 5: To understand service providers, policy makers, and other stakeholders perspectives on challenges of implementing and sustaining COVID-19-related prevention practices and continuity of care in PSH.

Interventions

None listed

Sponsors

University of California, Los Angeles
CollaboratorOTHER
University of Southern California
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adults (aged 18+) with recent (past 12 months) lived experience with homelessness * approved for PSH * proficient in English * able to provide informed consent

Exclusion criteria

* aged younger than 18 * not approved for PSH * not proficient in English * unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Quality of physical healthChange in quality of physical health from baseline to 6 monthsSelf-rated physical health and frequency/quantity of health-related activities will be assessed with the PROMIS Global Health Scale Version 1.2. Scores range from 1-10, with higher scores reflecting better functioning.
Social IsolationChange in social isolation from baseline to 6 monthsThe PROMIS will be utilized to assess social isolation including perceptions of being avoided, excluded, detached, disconnected from, or unknown by, others. Scores range from 6 to 40 with higher scores representing increased perceptions of isolation.
Housing EnvironmentChange in satisfaction with housing environment from baseline to 6 monthsThe Housing Environment Scale will assess residential satisfaction and neighborhood quality/safety. There are 5 subscales assessing the following: physical quality of the home, perceived quality of the neighborhood, perceived social climate in neighborhood, physical quality of home, and the physical quality of the neighborhood. Scales contain a range of 14 to 17 items with scores that range from 14 to 85 with higher scores representing increased satisfaction with environment.
Life SatisfactionChange of Life satisfaction from baseline to 6 monthsThe NIH Toolbox item Bank v2.0 contains 10 items and will be utilized for participants to self-rate their life satisfaction
Degree of mental health symptomatologyChange in symptomatology from baseline to 6 monthsThe PROMIS will also be utilized to assess self-rated frequency the participant is bothered by mental health symptoms. The lowest possible score is 8 and the highest possible score is 40. Higher scores reflect more problematic symptomatology.

Secondary

MeasureTime frameDescription
Healthcare UtilizationChange in utilization from baseline to 6 monthsParticipants will record their past 30-day use of physical and mental health treatment, social services, and support provided by the permanent supportive housing program
COVID-19 Prevention practicesChange in use of prevention practices from baseline to 6 monthsThe NIH Disaster Research Response Platform will assess participant frequency of handwashing, social distancing, and use of face covering.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026